Self-monitoring of blood glucose (SMBG) in patients with type 2 diabetes on oral anti-diabetes drugs: cost-effectiveness in France, Germany, Italy, and Spain

References

• Wild S, Roglic G, Green A, et al. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 2004;27:1047-53
   PubMed Web of Science ®Google Scholar
• Schnell O, Hummel M, Weber C. Economic and clinical aspects of diabetes regarding self-monitoring of blood glucose. Diabetes Technol Ther 2008;10:S72-81
   Web of Science ®Google Scholar
• Jonsson B. Revealing the cost of type 2 diabetes in Europe. Diabetologia 2002;45:S5-12
   PubMed Web of Science ®Google Scholar
• Wagner EH, Sandhu N, Newton KM, et al. Effect of improved glycemic control on heath care costs and utilization. JAMA 2001;285:182-9
   PubMed Web of Science ®Google Scholar
• Clarke P, Gray A, Legood R, et al. The impact of diabetes-related complications on healthcare costs: results from the United Kingdom Prospective Diabetes Study (UKPDS 65). Diabetes Med 2003;20:442-50
   PubMed Web of Science ®Google Scholar
• Stratton IM, Adler AL, Neil HA, et al. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes: prospective observational study (UKPDS 35). BMJ 2000;321:405-12
   PubMed Web of Science ®Google Scholar
• Menzin J, Boulanger L, Langley-Hawthorne C, et al. Potential short-term economic benefits of improved glycemic control. Diabetes Care 2001;24:24-51
   Web of Science ®Google Scholar
• The ADVANCE Collaborative Group. Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med 2008;358:2560-72
   PubMed Web of Science ®Google Scholar
• Skyler JS, Bergenstal RM, Bonow RO, et al. Intensive glycemic control and the prevention of cardiovascular events: implications of the ACCORD, ADVANCE, and VA diabetes trials. Diabetes Care 2009;32:187-92
   PubMed Web of Science ®Google Scholar
• The Action to Control Cardiovascular Risk in Diabetes Study Group. Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med 2008;358:2545-59
   PubMed Web of Science ®Google Scholar
• American Association of Clinical Endocrinologists. Medical guidelines for clinical practice for the management of diabetes mellitus. Endocrine Pract 2007;13. Available: http://www.aace.com/pub/pdf/guidelines/DMGuidelines2007.pdf (last accessed 10-30-2009)
   Google Scholar
• American Diabetes Association. Standards of medical care in diabetes. Diabetes Care 2004;27:S15-35
   PubMedGoogle Scholar
• National Institute for Health and Clinical Excellence (NICE). Type 2 diabetes. The management of type 2 diabetes (update of NICE clinical guidelines E, F, G, and H). 2008 May. http://www.nice.org.uk/guidance/ (last accessed 6-30-2009)
   Google Scholar
• Palmer A.J., Dinneen S, Gavin JR III, et al. Cost-utility analysis in a UK setting of self-monitoring of blood glucose in patients with type 2 diabetes. Curr Med Res Opin 2006;22:861-72
   PubMed Web of Science ®Google Scholar
• Scherbaum WA, Ohmann C, Abholz HH, et al. Effect of the frequency of self-monitoring of blood glucose in patients with type 2 diabetes treated with oral antidiabetic drugs – a multi-centre, randomized controlled trial. PLoS ONE 2008;3:1-5. Available from: URL: www.plosone.org (last accessed 12-15-2008)
   Google Scholar
• Tunis SL, Minshall ME. Self-monitoring of blood glucose in type 2 diabetes: Cost-effectiveness in the United States. Am J Manag Care 2008;14:131-40
   PubMed Web of Science ®Google Scholar
• Davis WA, Bruce DG, Davis TM. Is self-monitoring of blood glucose appropriate for all type 2 diabetic patients? The Freemantle Diabetes Study. Diabetes Care 2006;29:1764-70
   PubMed Web of Science ®Google Scholar
• Davis WA, Bruce DG, Davis TM. Does self-monitoring of blood glucose improve outcome in type 2 diabetes? The Fremantle Diabetes Study. Diabetologia 2007;50:510-55
   PubMed Web of Science ®Google Scholar
• Barnett AH, Krentz AJ, Strojek K, et al. The efficacy of self-monitoring of blood glucose in the management of patients with type 2 diabetes treated with a gliclazide modified release-based regimen. A multicentre, randomized, parallel-group, 6-month evaluation (DINAMIC 1 study). Diabetes Obes Metab 2008;10:1239-47
   PubMed Web of Science ®Google Scholar
• Guerci B, Drouin P, Grange V, et al. Self-monitoring of blood glucose significantly improves metabolic control in patients with type 2 diabetes mellitus: the Auto-Surveillance Intervention Active (ASIA) study. Diabetes Metab 2003;29:587-94
   PubMed Web of Science ®Google Scholar
• Muchmore DB, Springer J, Miller M. Self-monitoring of blood glucose in overweight type 2 diabetic patients. Acta Diabetol 1994;31:215-19
   PubMed Web of Science ®Google Scholar
• Schwedes U, Siebolds M, Mertes G, Group SS. Meal-related structured self-monitoring of blood glucose: effect on diabetes control in non-insulin-treated type 2 diabetic patients. Diabetes Care 2002;25:1928-32
   PubMed Web of Science ®Google Scholar
• Karter AJ, Parker MM, Moffet HH, et al. Longitudinal study of new and prevalent use of self-monitoring of blood glucose. Diabetes Care 2006;29:1757-63
   PubMed Web of Science ®Google Scholar
• Martin S, Schneider B, Heinemann L, et al. Self-monitoring of blood glucose in type 2 diabetes and long-term outcome: an epidemiological cohort study. Diabetologia 2006;49:271-8
   PubMed Web of Science ®Google Scholar
• Murata GH, Shah JH, Hoffman RM, et al. Intensified blood glucose monitoring improves glycemic control in stable, insulin-treated veterans with type 2 diabetes: The Diabetes Outcomes in Veterans Study (DOVES). Diabetes Care 2003;26:1759-63
   PubMed Web of Science ®Google Scholar
• O'Kane MJ, Bunting B, Copeland M, Coates VE. Efficacy of self monitoring of blood glucose in patients with newly diagnosed type 2 diabetes (ESMON study): randomised controlled trial. BMJ 2008;386:1174-7
   Google Scholar
• Davidson MB, Castellanos M, Kain D, Duran P. The effect of self monitoring of blood glucose concentrations on glycated hemoglobin levels in diabetic patients not taking insulin: a blinded, randomized trial. Am J Med 2005;118:422-5
   PubMed Web of Science ®Google Scholar
• Farmer A, Wade A, Goyder E, et al. Impact of self-monitoring of blood glucose in the management of patients with non-insulin treated diabetes: open parallel group randomised trial. BMJ 2007;335:132-9
   PubMed Web of Science ®Google Scholar
• Schutt M, Kern W, Krause U, et al. Is the frequency of self-monitoring of blood glucose related to long-term metabolic control? Multicenter analysis including 24,500 patients from 191 centers in Germany and Austria. Exp Clin Endocrinol Diabetes 2006;114:384-8
   PubMed Web of Science ®Google Scholar
• Weber C, Neeser K, Schneider B, et al. Self-measurement of blood glucose in patients with type 2 diabetes: a health economic assessment. J Diabetes Sci Technol 2007;1:676-84
   PubMedGoogle Scholar
• Simon J, Gray A, Clarke P, et al. Cost-effectiveness of self-monitoring of blood glucose in patients with non-insulin treated type 2 diabetes: economic evaluation of data from the DiGEM Trial. BMJ 2008;336:1177-80
   PubMed Web of Science ®Google Scholar
• Palmer AJ, Roze S, Valentine WJ, et al. The CORE Diabetes Model: projecting long term clinical outcomes, costs and cost-effectiveness of interventions in diabetes mellitus (types 1 and 2) to support clinical and reimbursement decision making. Curr Med Res Opin 2004;20:S5-26
   PubMed Web of Science ®Google Scholar
• Palmer AJ, Roze S, Valentine WJ, et al. Validation of the CORE Diabetes Model against epidemiological and clinical studies. Curr Med Res Opin 2004;20:S27-40
   PubMed Web of Science ®Google Scholar
• American Diabetes Association Consensus Panel. Guidelines for computer modeling of diabetes and its complications. Diabetes Care 2004;27:2262-5
   PubMed Web of Science ®Google Scholar
• The UK Prospective Diabetes Study Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998;352:837-53
   PubMed Web of Science ®Google Scholar
• Stevens RJ, Stratton IM, Holman RR. Modeling glucose exposure as a risk factor for photocoagulation in type 2 diabetes (UKPDS 58). J Diabetes Complic 2002;16:371-6
   PubMed Web of Science ®Google Scholar
• Kothari V, Stevens RJ, Adler AI, et al. Risk of stroke in type 2 diabetes estimated by the UK Prospective Diabetes Study risk engine (UKPDS 60). Stroke 2002;33:1776-81
   PubMed Web of Science ®Google Scholar
• Stratton IM, Kohner EM, Aldington SJ, et al. Risk factors for incidence and progression of retinopathy in type II diabetes over 6 years from diagnosis (UKPDS 50). Diabetologia 2001;44:156-63
   PubMed Web of Science ®Google Scholar
• Karter AJ, Ackerson LM, Darbinian JA, et al. Self-monitoring of blood glucose levels and glycemic control: The Northern California Kaiser Permanente Diabetes Registry. Am J Med 2001;111:1-9
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention (CDC). National Center for Health Statistics (NCHS). National Health and Nutrition Examination Survey (NHANES) 1999-2000 Dataset: Diabetes Survey. US Department of Health and Human Services, Hyattsville, MD, 2000. Available: http://www.cdc.gov/nchs/data/nhanes/spq-di.pdf (last accessed 3-3-2008)
   Google Scholar
• Harris MI. Health care and health status and outcomes for patients with type 2 diabetes. Diabetes Care 2000;23:754-8
   PubMed Web of Science ®Google Scholar
• Brändle M, Zhou H, Smith BRK, et al. The direct medical cost of type 2 diabetes. Diabetes Care 2003;26:2300-4
   PubMed Web of Science ®Google Scholar
• Klein R, Klein BEK. Vision disorders in diabetes. In: Harris MI, Cowie CC, Stern MP, eds. Diabetes in America, 2nd edn. Bethesda, MD: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), National Institutes of Health; 1995. Report number 95-1468. Available: http://diabetes.niddk.nih.gov/dm/pubs/america/contents.htm (last accessed 7-7-2007)
   Google Scholar
• Moss SE, Klein R, Klein BE. The prevalence and incidence of lower extremity amputation in a diabetic population. Arch Intern Med 1992;152:610-16
   PubMed Web of Science ®Google Scholar
• Ray JA, Valentine WJ, Secnik K, et al. Review of the cost of diabetes complications in Australia, Canada, France, Germany, Italy and Spain. Curr Med Res Opin 2005;21:1617-29
   PubMed Web of Science ®Google Scholar
• ISPOR Global Health Care Systems Road Map. Reimbursement Processes Around the World. ISPOR Website 2008 October 1; http://www.ispor.org/HTARoadMaps (last accessed 8-29-2009)
   Google Scholar
• Institute for Quality and Efficiency in Heath Care. Methods for Assessment of the Relation of Benefits to Costs in the German Statutory Health Care System. March 16, 2009. http://www.iqwig.de/index.en.html (last accessed 8-24-2009)
   Google Scholar
• Clarke P, Gray A, Holman R. Estimating utility values for health states of type 2 diabetic patients using the EQ-5D (UKPDS 62). Med Decis Making 2002;22:340-9
   PubMed Web of Science ®Google Scholar
• Tengs TO, Wallace A. One thousand health-related quality-of-life estimates. Med Care 2000;38:583-637
   PubMed Web of Science ®Google Scholar
• Begg S, Vos T, Barker B, et al. The Burden of Disease and Injury in Australia 2003. Australian Institute of Health and Welfare, 2007. Available: http://www.aihw.gov.au/publications/index.cfm/title/10317 (last accessed 3-3-2008)
   Google Scholar
• Carrington AL, Mawdsley SK, Morley M, et al. Psychological status of diabetic people with or without lower limb disability. Diabetes Res Clin Pract 1996;32:19-25
   PubMed Web of Science ®Google Scholar
• National Institute for Health and Clinical Excellence (NICE). Guidance on the use of long-acting insulin analogues for the treatment of diabetes-insulin glargine, Technology Appraisal Guidance Report No. 53, 2002. Available: http://www.nice/org.uk/nicemedia/pdf/53 (last accessed 4-20-2008)
   Google Scholar
• Halpern EF, Weinstein MC, Hunink MG, et al. Representing both first- and second-order uncertainties by Monte Carlo simulation for groups of patients. Med Decis Making 2000;20:314-22
   PubMed Web of Science ®Google Scholar
• Briggs A, Wonderling D, Mooney C. Pulling cost-effectiveness analysis up by its bootstraps: a non-parametric approach to confidence interval estimation. Health Econ 1997;6:327-40
   PubMed Web of Science ®Google Scholar
• Bergenstal RM, Gavin JR III. The role of self-monitoring of blood glucose in the care of people with diabetes: report of a global consensus conference. Am J Med 2006;118:1-6S
   Web of Science ®Google Scholar
• Klonoff DC, Bergenstal RM, Blonde L, et al. Consensus report of the coalition for clinical research-self-monitoring of blood glucose. J Diabetes Sci Tech 2008;2:1030-52
   PubMedGoogle Scholar
• International Diabetes Federation. Global Guidelines for Type 2 Diabetes. 2005. http://www.idf.org/Global guideline (last accessed 7-11-2009)
   Google Scholar
• Claxton K, Buxton MJ, Culyer A, et al. Value based pricing for NHS drugs: an opportunity not to be missed?. BMJ 2008;336:251-4
   PubMed Web of Science ®Google Scholar
• Klonoff DC. New evidence demonstrates that self-monitoring of blood glucose does not improve outcomes in type 2 diabetes-when the practice is not applied properly. J Diabetes Sci Technol 2008;2:342-8
   PubMedGoogle Scholar
• Schnell O, Heinemann L. Self-monitoring of blood glucose in noninsulin-treated patients with type 2 diabetes: a never ending story?. J Diabetes Sci Technol 2007;1:614-16
   PubMedGoogle Scholar
• Nielsen JK, Christiansen JS. Self-monitoring of blood glucose--epidemiological and practical aspects. Diabetes Technol Ther 2008;10:S35-42
   Web of Science ®Google Scholar
• Canadian Optimal Medication Prescribing and Utilization Service (COMPUS). Cost-effectiveness of blood glucose test strips in the management of adult patients with diabetes mellitus. Canadian Agency for Drugs and Technologies in Health (CADTH); 2009 Mar 1. http://www.cadth.ca/media/pdf/BGTS_Consolidated_Economic_Report.pdf (last accessed 9-3-2009)
   Google Scholar
• Goyder E. Should we stop patients with non-insulin treated diabetes using self-monitoring of blood glucose? The implications of the Diabetes Glycaemic Education and Monitoring (DiGEM) trial. Prim Care Diabetes 2008;2:91-3
   PubMedGoogle Scholar
• Soumerai S, Mah C, Zhang F, et al. Effects of health maintenance organization of self-monitoring devices on diabetes self-care and glycemic control. Arch Intern Med 2004;164:645-52
   PubMed Web of Science ®Google Scholar
• McEwan PC, Chamberlain GH, Griffin AD. Association between self monitoring of blood glucose and HbA1c in UK primary care. Poster presented at Diabetes UK Annual Professional Conference, Glasgow, Scotland, 11-13 March, 2009
   Google Scholar
• O'sullivan A, Thompson D. Country-to-country adaptation of pharmacoeconomic research: methodologic challenges and potential solutions. ISPOR Connections, Jan-Feb, 2009
   Google Scholar